132 related articles for article (PubMed ID: 272946)
1. Acute leukemia after chemotherapy (melphalan).
Einhorn N
Cancer; 1978 Feb; 41(2):444-7. PubMed ID: 272946
[TBL] [Abstract][Full Text] [Related]
2. Acute leukemia after alkylating-agent therapy of ovarian cancer.
Reimer RR; Hoover R; Fraumeni JF; Young RC
N Engl J Med; 1977 Jul; 297(4):177-81. PubMed ID: 406560
[TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma terminating in acute leukemia: report of two cases and review of the literature.
Martínez-Poventud G; Fernández AC; Vélez-García E
Bol Asoc Med P R; 1985 Oct; 77(10):419-21. PubMed ID: 3865657
[No Abstract] [Full Text] [Related]
4. Acute leukemia after melphalan treatment for ovarian carcinoma.
Blythe JC
J Med Assoc State Ala; 1977 Nov; 47(5):42-3, 57. PubMed ID: 925549
[No Abstract] [Full Text] [Related]
5. Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials.
Greene MH; Boice JD; Greer BE; Blessing JA; Dembo AJ
N Engl J Med; 1982 Dec; 307(23):1416-21. PubMed ID: 6752720
[TBL] [Abstract][Full Text] [Related]
6. Melphalan-related leukemia in multiple myeloma.
Wahlin A; Roos G; Rudolphi O; Holm J
Acta Med Scand; 1982 May; 211(3):203-8. PubMed ID: 7080865
[TBL] [Abstract][Full Text] [Related]
7. Acute leukemia in a patient with ovarian cancer treated with cisplatin-based chemotherapy and alkeran.
Markman M; Hoskins WB
Cancer Invest; 1990; 8(1):113-4. PubMed ID: 2350715
[No Abstract] [Full Text] [Related]
8. Melphalan may be a more potent leukemogen than cyclophosphamide.
Greene MH; Harris EL; Gershenson DM; Malkasian GD; Melton LJ; Dembo AJ; Bennett JM; Moloney WC; Boice JD
Ann Intern Med; 1986 Sep; 105(3):360-7. PubMed ID: 3740675
[TBL] [Abstract][Full Text] [Related]
9. Ovarian carcinoma terminating in acute nonlymphocytic leukemia following alkylating agent therapy.
Kapadia SB; Krause JR
Cancer; 1978 May; 41(5):1676-9. PubMed ID: 417794
[TBL] [Abstract][Full Text] [Related]
10. Late side effects of chemotherapy in ovarian carcinoma: a cytogenetic, hematologic, and statistical study.
Einhorn N; Eklund G; Franzén S; Lambert B; Lindsten J; Söderhäll S
Cancer; 1982 Jun; 49(11):2234-41. PubMed ID: 7074540
[TBL] [Abstract][Full Text] [Related]
11. [Induced malignant hemopathies. 6 new cases with 1 patient surviving 45 months].
Clément F
Schweiz Med Wochenschr; 1979 Apr; 109(15):544-51. PubMed ID: 286415
[TBL] [Abstract][Full Text] [Related]
12. Acute leukaemia after alkylating-agent therapy of ovarian cancer.
Bell DR; Woods RL; Levi JA
Med J Aust; 1982 Sep; 2(5):243-4. PubMed ID: 7132879
[No Abstract] [Full Text] [Related]
13. [Pyoderma gangrenosum, ovarian carcinoma treated with Melphalan and acute myelomonocytic leukaemia: report of one case and literature review (author's transl)].
Ortonne JP; Thivolet J; Chouvet B; Coiffet J
Ann Dermatol Venereol; 1979 Mar; 106(3):251-6. PubMed ID: 290349
[TBL] [Abstract][Full Text] [Related]
14. [Acute erythroleukemia in a melphalan-treated patient with cold agglutination syndrome].
Stavem P; Harboe M
Nord Med; 1971; 86(49):1494. PubMed ID: 5289909
[No Abstract] [Full Text] [Related]
15. Epistaxis and severe weakness in a patient with multiple myeloma. Therapy-related acute myeloid leukemia, pure erythroid leukemia.
Guo C; Inghirami G; Ibrahim S; Sen F
Arch Pathol Lab Med; 2006 Jul; 130(7):1075-6. PubMed ID: 16831041
[TBL] [Abstract][Full Text] [Related]
16. Erythroleukemia following melphalan therapy for multiple myeloma.
Fishman SA; Ritz ND
N Y State J Med; 1975 Nov; 75(13):2402-4. PubMed ID: 1059018
[No Abstract] [Full Text] [Related]
17. Chemical leukemogenesis in man.
Forni A; Vigliani EC
Ser Haematol; 1974; 7(2):211-23. PubMed ID: 4610755
[No Abstract] [Full Text] [Related]
18. Acute leukemia in advanced ovarian carcinoma after treatment with alkylating agents.
Sotrel G; Jafari K; Lash AF; Stepto RC
Obstet Gynecol; 1976 Jan; 47(1):67S-71S. PubMed ID: 1061006
[TBL] [Abstract][Full Text] [Related]
19. Leukemia following chemotherapy for ovarian cancer.
Kaldor JM; Day NE; Pettersson F; Clarke EA; Pedersen D; Mehnert W; Bell J; Høst H; Prior P; Karjalainen S
N Engl J Med; 1990 Jan; 322(1):1-6. PubMed ID: 2104664
[TBL] [Abstract][Full Text] [Related]
20. Leukemia after treatment of ovarian cancer with alkylating agents.
Parker LM
N Engl J Med; 1983 Jun; 308(23):1422. PubMed ID: 6843637
[No Abstract] [Full Text] [Related]
[Next] [New Search]
